Literature DB >> 18821049

Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss.

G R W Moore1, C Laule, A Mackay, E Leung, D K B Li, G Zhao, A L Traboulsee, D W Paty.   

Abstract

"Dirty-appearing white matter" (DAWM) in multiple sclerosis (MS) is defined as a region(s) with ill-defined borders of intermediate signal intensity between that of normal-appearing white matter (NAWM) and that of plaque on T(2)-weighted and proton density imaging. To delineate the histopathology of DAWM, four formalin-fixed cerebral hemisphere slices of three MS patients with DAWM were scanned with T(2)- weighted and proton density sequences. The myelin water fraction (MWF) was obtained by expressing the short T(2) component as a fraction of the total T(2) distribution. Hemispheric sections were then stained with Luxol fast blue (LFB) for myelin phospholipids, for myelin basic protein (MBP) and 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP) for myelin; Bielschowsky silver impregnation for axons; and for glial fibrillary acidic protein (GFAP) for astrocytes. Compared to NAWM, DAWM showed reduction in MWF, corresponding to a reduction of LFB staining. DAWM also showed reduced Bielschowsky staining. Quantitatively, the change in MWF in DAWM most consistently correlated with the change in LFB staining. The findings of this preliminary study suggest that DAWM is characterized by loss of myelin phospholipids, detected by the short T(2) component, and axonal reduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821049     DOI: 10.1007/s00415-008-0002-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  49 in total

1.  Lipid chemistry of the brain in demyelinating diseases.

Authors:  J N CUMINGS
Journal:  Brain       Date:  1955       Impact factor: 13.501

2.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

3.  Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation.

Authors:  M Daumer; L M Griffith; W Meister; R A Nash; J S Wolinsky
Journal:  Mult Scler       Date:  2006-04       Impact factor: 6.312

4.  The binding of luxol fast blue ARN by various biological lipids.

Authors:  R M Lycette; W F Danforth; J L Koppel; J H Olwin
Journal:  Stain Technol       Date:  1970-07

5.  The topography of plaques in multiple sclerosis with special reference to cerebral plaques.

Authors:  T Fog
Journal:  Acta Neurol Scand Suppl       Date:  1965

6.  Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.

Authors:  Nicola De Stefano; Sridar Narayanan; Simon J Francis; Steve Smith; Marzia Mortilla; M Carmela Tartaglia; Maria L Bartolozzi; Leonello Guidi; Antonio Federico; Douglas L Arnold
Journal:  Arch Neurol       Date:  2002-10

7.  Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology.

Authors:  C Laule; E Leung; D K B Lis; A L Traboulsee; D W Paty; A L MacKay; G R W Moore
Journal:  Mult Scler       Date:  2006-12       Impact factor: 6.312

8.  Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.

Authors:  A Traboulsee; J Dehmeshki; Kevin R Peters; C M Griffin; P A Brex; N Silver; O Ciccarrelli; D T Chard; G J Barker; A J Thompson; D H Miller
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

9.  A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.

Authors:  H E Gendelman; G H Pezeshkpour; N J Pressman; J S Wolinsky; R H Quarles; M J Dobersen; B D Trapp; C A Kitt; A Aksamit; R T Johnson
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

Review 10.  The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis.

Authors:  F Fazekas; F Barkhof; M Filippi; R I Grossman; D K Li; W I McDonald; H F McFarland; D W Paty; J H Simon; J S Wolinsky; D H Miller
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

View more
  21 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.

Authors:  H Vrenken; A Seewann; D L Knol; C H Polman; F Barkhof; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

3.  Dirty-appearing white matter: a disregarded entity in multiple sclerosis.

Authors:  M Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

4.  Assessing structure and function of myelin in cervical spondylotic myelopathy: Evidence of demyelination.

Authors:  Hanwen Liu; Erin L MacMillian; Catherine R Jutzeler; Emil Ljungberg; Alex L MacKay; Shannon H Kolind; Burkhard Mädler; David K B Li; Marcel F Dvorak; Armin Curt; Cornelia Laule; John L K Kramer
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

Review 5.  Quantitative relaxometry of the brain.

Authors:  Sean C L Deoni
Journal:  Top Magn Reson Imaging       Date:  2010-04

Review 6.  The immunopathophysiology of multiple sclerosis.

Authors:  Gregory F Wu; Enrique Alvarez
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

7.  A Model of Population and Subject (MOPS) Intensities With Application to Multiple Sclerosis Lesion Segmentation.

Authors:  Xavier Tomas-Fernandez; Simon K Warfield
Journal:  IEEE Trans Med Imaging       Date:  2015-01-19       Impact factor: 10.048

8.  Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.

Authors:  Kerstin Bendfeldt; Jan Ole Blumhagen; Hanspeter Egger; Patrick Loetscher; Niklaus Denier; Pascal Kuster; Stefan Traud; Nicole Mueller-Lenke; Yvonne Naegelin; Achim Gass; Jochen Hirsch; Ludwig Kappos; Thomas E Nichols; Ernst-Wilhelm Radue; Stefan J Borgwardt
Journal:  Hum Brain Mapp       Date:  2010-10       Impact factor: 5.038

Review 9.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

10.  Blood pressure and sodium: Association with MRI markers in cerebral small vessel disease.

Authors:  Anna K Heye; Michael J Thrippleton; Francesca M Chappell; Maria del C Valdés Hernández; Paul A Armitage; Stephen D Makin; Susana Muñoz Maniega; Eleni Sakka; Peter W Flatman; Martin S Dennis; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.